Načítá se...
In silico repurposing of antipsychotic drugs for Alzheimer’s disease
BACKGROUND: Alzheimer’s disease (AD) is the most prevalent form of dementia and represents one of the highest unmet requirements in medicine today. There is shortage of novel molecules entering into market because of poor pharmacokinetic properties and safety issues. Drug repurposing offers an oppor...
Uloženo v:
| Vydáno v: | BMC Neurosci |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
BioMed Central
2017
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5660441/ https://ncbi.nlm.nih.gov/pubmed/29078760 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12868-017-0394-8 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|